We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
88 hedge funds and large institutions have $98.7M invested in scPharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,977% more call options, than puts
Call options by funds: $400K | Put options by funds: $13K
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
27% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 26
4% more funds holding
Funds holding: 85 → 88 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.82% less ownership
Funds ownership: 79.49% → 74.67% (-4.8%)
30% less capital invested
Capital invested by funds: $141M → $98.7M (-$42.1M)
Holders
88
Holders Change
+3
Holders Change %
+3.53%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
33
Reduced
26
Closed
8
Calls
$400K
Puts
$13K
Net Calls
+$387K
Net Calls Change
-$149K
Top Buyers
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$6.52M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.31M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$2.06M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.09M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.05M |
